Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Support

This activity is supported by an educational grant from Sanofi Genzyme.

Expert Illustrations & Commentaries: Exploring the Role of BTK Inhibition in the Treatment of Multiple Sclerosis

Release Date: July 30, 2021
Expiration Date: July 30, 2022

Activity Overview

This activity is a video-based program in which 2 experts discuss the etiology and management of multiple sclerosis (MS). In this activity, the faculty focus on the pathophysiology of MS as it relates to Bruton’s tyrosine kinase (BTK), as well as clinical trial data on the efficacy and safety of novel BTK inhibitors in MS treatment. Their discussion is enriched with the use of video animations to illustrate MS pathophysiology, as well as the mechanism of action of BTK inhibitors in MS. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of MS and to improve outcomes for their patients with this disease.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward neurologists, and other health care professionals who treat patients with multiple sclerosis.

Learning Objectives

Upon succesl completion of this activity, you should be better prepared to:

  • Discuss the inflammatory pathophysiology of MS as related to BTK
  • Describe the safety and efficacy of BTK inhibitors in the management of patients with relapsed-remitting and progressive forms of MS
  • Incorporate recent and emerging data into case-based treatment strategies for MS based on patient-specific needs

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Claire S. Riley, MD
Claire S. Riley, MD
Karen L. K. Miller Assistant Professor of Neurology
Medical Director, Columbia Multiple Sclerosis Center
Division of Neuroimmunology
Department of Neurology
Columbia University Irving Medical Center
New York, NY

Disclosures: Consultant: Genentech.

Stephen Krieger, MD, FAAN
Stephen Krieger, MD, FAAN
Professor of Neurology
Corinne Goldsmith Dickinson Center for MS
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Grant/Research Support: Biogen, Novartis Pharmaceuticals; Consultant: Biogen, EMD Serono, Genentech, Sanofi Genzyme, Mallinckrodt Pharmaceuticals, MedDay Pharmaceuticals, Novartis Pharmaceuticals, Octave Bioscience, Teva Pharmaceuticals, TG Therapeutics; Speakers’ Bureau: Nonpromotional speaking: Biogen, EMD Serono, Genentech, Novartis Pharmaceuticals.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By